계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Biosortia Microbiomics
company
About
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
- 11 - 50
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $8M
- Industries
- Artificial Intelligence,Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2012
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Biosortia Microbiomics has unique access to the hidden chemistry of the microbiome. The only capability in the world to obtain the long-sought, but previously unobtainable drug-like molecules directly from the microbiome leading to direct access of hidden molecules and filling the key missing data for artificial intelligence (AI).
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$8M
Biosortia Microbiomics has raised a total of
$8M
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2016 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2016 | Seed | $8M | 1 |
Keiretsu Forum
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Biosortia Microbiomics is funded by 1 investors.
Keiretsu Forum
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Keiretsu Forum
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
